NCT07295132 2025-12-19RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)Asan Medical CenterPhase 2 Not yet recruiting160 enrolled
NCT06014528 2025-04-30IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian CancerInxMed (Shanghai) Co., Ltd.Phase 2 Recruiting168 enrolled